QUIMDIS / ARJUNA – Innovation in joint health formulas: The synergy of 2 powerfull active ingredients

The Indian company ARJUNA, specialized in active plants, published a clinical study with a combination of BCM95® (a patented Curcuma longa extract) and AKBAMAX™ (a Boswellia serrata extract.) for the osteoarthritis. The result of this association showed a significant reduction of joint pain thanks to an inhibition of the two inflammatory pathways: Cyclooxygenase-2 pathway for BCM95® and 5-Lipoxygenase pathway for AKBAMAX®.
BCM95® is the only 100% Curcuma longa extract with high bioavailability and bioactivity without use of additives. The unique combination of curcuminoids and turmeric essential oils allows an enhanced oral bioavailability (7 times higher than a standard extract) and retention of curcumin in blood (even after 8H).
AKBAMAX® is a unique Boswellia serrata extract with synergism of acetyl group of boswellic acids. It is standardized with 10% of AKBA. Compared to a standard extract, AKBAMAX® is five times more potent.
These two extracts are suitable for tablets, capsules, sticks, sachets, etc…
They are distributed in France by Quimdis in accordance with the European and French regulations.

Visit Quimdis’ booth

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s